Pneumococcal Vaccine (PPSV)
Information about the pneumococcal polysaccharide vaccine that helps protect against Streptococcus pneumoniae
USA only. If you or someone you know is in immediate danger, call 911. If you need someone to talk to right now, call or text 988.
Overview
The pneumococcal polysaccharide vaccine (PPSV) helps protect against Streptococcus pneumoniae, a bacterium that can cause serious and potentially life-threatening infections, particularly in older adults and people with certain medical conditions.
What It Protects Against
- •Pneumonia
- •Bloodstream infections (bacteremia/sepsis)
- •Meningitis
Who It's For
- •Adults 65 years and older (depending on prior vaccination history)
- •Adults 19–64 with certain chronic conditions (such as heart disease, lung disease, diabetes)
- •People with weakened immune systems or specific risk factors
- •Individuals with cochlear implants or cerebrospinal fluid leaks
Routine Schedule
- •Often given as a single dose
- •Some individuals may require additional doses based on age, medical condition, or previous pneumococcal vaccination
- •PPSV may be given alone or after a PCV vaccine, depending on clinical guidance
Safety & Notes
- •Inactivated (non-live) vaccine
- •Cannot cause pneumococcal disease
- •Common side effects include arm soreness, redness, or mild fever
- •Serious adverse reactions are rare
Important Distinction
- •PPSV protects against more pneumococcal strains
- •PCV produces a stronger immune response in certain populations
- •Healthcare providers determine whether PCV, PPSV, or both are recommended
Access & Cost
Pneumococcal vaccines are commonly covered by Medicare, Medicaid, private insurance, and public health programs when eligibility criteria are met.
Important Disclaimer
Hospitals.net provides informational content only and does not provide medical advice. Vaccination decisions should be made in consultation with a qualified healthcare professional.